Stockreport

Cancer Drug Maker Arcus Surges as Street Touts $10 Billion Opportunity With Gilead [Yahoo! Finance News]

Arcus Biosciences, Inc.  (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report
PDF ) -- Arcus Biosciences Inc., which is working in a category of new cancer medicines estimated to be worth as much $10 billion, nearly doubled after reported that Gilead [Read more]